Evidence map›Paper›PMID 21763735›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2011

Multimodal imaging of sustained drug release from 3-D poly(propylene fumarate) (PPF) scaffolds.

Jonghoon Choi, Kyobum Kim, Taeho Kim, Guanshu Liu, Amnon Bar-Shir, Taeghwan Hyeon, Michael T McMahon, Jeff W M Bulte, John P Fisher, Assaf A Gilad

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Pre- and postmortem imaging of transplanted cells.International journal of nanomedicine · 2015
    Review
  18. Stimuli-responsive theragrippers for chemomechanical controlled release.Angewandte Chemie (International ed. in English) · 2014
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jonghoon ChoiRussell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Kyobum Kim
Taeho Kim
Guanshu Liu
Amnon Bar-Shir
Taeghwan Hyeon
Michael T McMahon
Jeff W M Bulte
John P Fisher
Assaf A Gilad

Funding

Developing a CEST Reporter Gene (RMI)R21EB005252 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI BULTE, JEFF W. · 2005 to 2008
$1.4M
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell TrackingK01EB006394 · NIBIB · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI MCMAHON, MICHAEL T · 2006 to 2010
$619k
Imaging of gene delivery in the central nervous systemR21EB008769 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI GILAD, ASSAF A · 2009 to 2010
$458k
Monitoring Neuronal Activity and Inducible Gene Expression using MRIR21NS065284 · NINDS · JOHNS HOPKINS UNIVERSITY · PI GILAD, ASSAF A · 2009 to 2010
$411k
NIBIB NIH HHS K01 EB006394NIBIB NIH HHS R21 EB005252NIBIB NIH HHS R21 EB008769NINDS NIH HHS R21 NS065284
6 · The paper itself

Abstract

The potential of poly(propylene fumarate) (PPF) scaffolds as drug carriers was investigated and the kinetics of the drug release quantified using magnetic resonance imaging (MRI) and optical imaging. Three different MR contrast agents were used for coating PPF scaffolds. Initially, iron oxide (IONP) or manganese oxide nanoparticles (MONP) carrying the anti-cancer drug doxorubicin were absorbed or mixed with the scaffold and their release into solution at physiological conditions was measured with MRI and optical imaging. A slow (hours to days) and functional release of the drug molecules into the surrounding solution was observed. In order to examine the release properties of proteins and polypeptides, protamine sulfate, a chemical exchange saturation transfer (CEST) MR contrast agent, was attached to the scaffold. Protamine sulfate showed a steady release rate for the first 24h. Due to its biocompatibility, versatile drug-loading capability and constant release rate, the porous PPF scaffold has potential in various biomedical applications, including MR-guided implantation of drug-dispensing materials, development of drug carrying vehicles, and drug delivery for tumor treatment.

Indexed as

Antibiotics, AntineoplasticCell Line, TumorDoxorubicinDrug CarriersFumaratesHumansMagnetic Resonance ImagingNeoplasmsPolypropylenesProtaminesTissue ScaffoldsAntibiotics, AntineoplasticDoxorubicinDrug CarriersFumaratespoly(propylene fumarate)PolypropylenesProtamines

Identifiers

PMID21763735
PMCPMC3202643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.